EUROIMMUNBlog Medizinische Labordiagnostika AG

  • Reflecting on a decade of collaborating excellence: 10 years of neurology at Wieslab AB
    by EUROIMMUN AG on February 7, 2024 at 7:41 am

    A decade ago, an excellent collaboration began for the benefit of neurological diagnostics: Wieslab AB is celebrating its 10th anniversary in neurology ‒ together with EUROIMMUN. We wanted to know what is behind this successful concept and asked Lina Tebbla, Global Technology Manager from Wieslab: Dear Lina, can you provide an overview of your diagnostic Der Beitrag Reflecting on a decade of collaborating excellence: 10 years of neurology at Wieslab AB erschien zuerst auf EUROIMMUNBlog.

  • Updated COVID-19 XBB.1.5 vaccines elicit strong immune responses to new SARS-CoV-2 variants
    by Scientific Study Management on January 15, 2024 at 7:49 am

    Two new studies on SARS-CoV-2 vaccine immune responses suggest that the XBB.1.5-containing mRNA vaccines most likely increase protection against COVID-19 caused by currently circulating XBB variants and the emerging BA.2.86 variant in healthy persons and in patients on haemodialysis. The studies build on collaborative work between the Hannover Medical School, Germany and EUROIMMUN and were Der Beitrag Updated COVID-19 XBB.1.5 vaccines elicit strong immune responses to new SARS-CoV-2 variants erschien zuerst auf EUROIMMUNBlog.

  • EUROIMMUN’s portfolio for therapeutic drug monitoring is expanding
    by Dr. Lena Baumecker on November 14, 2023 at 12:29 pm

    EUROIMMUN has been offering test systems for therapeutic drug monitoring (TDM) since 2019. Owing to the cooperation with IDS and their range of TDM products from Theradiag, we were able to significantly expand our portfolio: We are now offering ELISA and ChLIA test systems for the therapeutic monitoring of different biologics and antibodies against them Der Beitrag EUROIMMUN’s portfolio for therapeutic drug monitoring is expanding erschien zuerst auf EUROIMMUNBlog.

  • Immunoblots: an old friend with a new face – An interview with EUROIMMUN
    by Dr. Anne Rupprecht on November 2, 2023 at 10:25 am

    Immunoblots are an important laboratory-diagnostic tool to detect autoimmune diseases, allergies and infectious diseases. They enable monospecific detection of many different antibodies and, simultaneously, their differentiation. Especially autoimmune diseases, such as myositis, may be caused by manifold antibodies– many of them occurring with very low prevalences. This often leads to a long search and the Der Beitrag Immunoblots: an old friend with a new face – An interview with EUROIMMUN erschien zuerst auf EUROIMMUNBlog.

  • Ultrafast immunofluorescence microscopy – now with 89 new products for autoimmune and infection diagnostics
    by Swantje Seifert on September 29, 2023 at 2:16 pm

    Our main goal is to offer our customers not only a broad range of assays, but also a flexible choice of automation solutions. Therefore, this year, we have provided proofs of compatibility for a total of 89 indirect immunofluorescence tests (IIFT) with the automated EUROPattern Microscope Live. Now, our fastest microscope can be used on Der Beitrag Ultrafast immunofluorescence microscopy – now with 89 new products for autoimmune and infection diagnostics erschien zuerst auf EUROIMMUNBlog.

    Feed has no items.